NKF-K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy

Acronyms and Abbreviations

Introduction

I. Measurement of Hemodialysis Adequacy

II. Hemodialysis Dose

III. Blood Urea Nitrogen (BUN) Sampling

IV. Hemodialyzer Reprocessing and Reuse

V. Hemodialysis Dose Troubleshooting

VI. Maximizing Patient Adherence to the Hemodialysis Prescription

VII. References

VIII. Appendices

IX. Biographical Sketches of the NKF-K/DOQI Hemodialysis Adequacy Work Group Members

II. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR PERITONEAL DIALYSIS ADEQUACY: UPDATE 2000

Acronyms and Abbreviations

Introduction

I. Initiation of Dialysis

II. Measures of Peritoneal Dialysis Dose

III. Measurement of Peritoneal Dialysis Dose

IV. Assessment of Nutritional Status Specifically as It Relates to Peritoneal Dialysis

V. Adequate Dose of Peritoneal Dialysis

VI. Strategies for Increasing the Likelihood of Achieving the Prescribed Dose of Peritoneal Dialysis

VII. Clinical Outcome Goals for Adequate Peritoneal Dialysis

VIII. Suitable Patients for Peritoneal Dialysis

IX. References

X. Appendices

XI. Biographical Sketches of the NKF-K/DOQI Peritoneal Dialysis Adequacy Work Group Members

III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000

Acronyms and Abbreviations

Introduction

I. Patient Evaluation Prior to Access Placement

II. Monitoring, Surveillance, and Diagnostic Testing

III. Prevention of Complications: Infection

IV. Management of Complications: When to Intervene

V. Management of Complications: Optimal Approaches for Treating Complications

VI. Potential Quality of Care Standards

VII. References

VIII. Biographical Sketches of the NKF-K/DOQI Vascular Access Work Group Members

IV. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR ANEMIA OF CHRONIC KIDNEY DISEASE: UPDATE 2000

Acronyms and Abbreviations

Introduction

I. Anemia Work-Up

II. Target Hemoglobin/Hematocrit

III. Iron Support

IV. Administration of Epoetin

V. Inadequate Epoetin Response

VI. Role of Red Blood Cell Transfusions

VII. Possible Adverse Effects Related to Epoetin Therapy

VIII. Endnotes

IX. References

X. Biographical Sketches of the NKF-K/DOQI Anemia Work Group Members

The Renal Network, Inc.
911 E. 86th Street, Suite 202
Indianapolis, IN 46240
Phone: (317) 257-8265
Fax: (317) 257-8291
Patient Line:
1 (800) 456-6919
Email: [email protected]